EVOLUS, INC.

EOLS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $84.1M $73.1M $90.3M $69.0M $69.4M $68.5M $78.9M $61.1M
Cost of Revenue $26.9M $24.2M $31.0M $23.1M $24.1M $21.9M $26.3M $19.0M
Gross Profit $57.2M $48.9M $59.3M $45.8M $45.3M $46.7M $52.6M $42.1M
Gross Margin 68.0% 66.9% 65.7% 66.5% 65.3% 68.1% 66.7% 68.9%
Operating Expenses
Research & Development
SG&A Expense $57.1M $52.0M $54.7M $52.8M $56.7M $56.6M $50.2M $52.5M
Operating Income $-4.5M $-6.8M $4.2M $-11.5M $-10.2M $-15.2M $-2.3M $-15.5M
Operating Margin -5.4% -9.4% 4.7% -16.7% -14.7% -22.1% -2.9% -25.3%
Interest Expense
Pretax Income $-8.2M $-10.4M $515.0K $-15.6M $-17.1M $-18.8M $-6.4M $-19.0M
Income Tax Expense $-154.0K $256.0K $385.0K $167.0K $53.0K $72.0K $440.0K $134.0K
Net Income $-8.1M $-10.7M $130.0K $-15.7M $-17.1M $-18.9M $-6.8M $-19.2M
Net Margin -9.6% -14.6% 0.1% -22.8% -24.7% -27.6% -8.6% -31.4%
EPS (Basic) $-0.12 $-0.16 $0.01 $-0.24 $-0.27 $-0.30 $-0.11 $-0.30
EPS (Diluted) $-0.12 $-0.16 $0.01 $-0.24 $-0.27 $-0.30 $-0.11 $-0.30
Shares Outstanding (Basic) 65.9M 65.2M 64.5M 64.7M 64.5M 63.7M 62.0M 63.1M
Shares Outstanding (Diluted) 65.9M 65.2M 64.5M 64.7M 64.5M 63.7M 62.0M 63.1M
Dividends Per Share
← Newer Page 1 of 4 Older →